AKAP-4: A novel cancer testis antigen for multiple myeloma [2]

British Journal of Haematology

Volumn 140, Issue 4, 2008, Pages 465-468

  Chiriva Internati, Maurizio ^a,b   Ferrari, Raffaele ^a,b   Yu, Yuefei ^a,b   Hamrick, Cody ^a,b   Gagliano, Nicoletta ^c   Grizzi, Fabio ^b,d   Frezza, Eldo ^a,b   Jenkins, Marjorie R ^e   Hardwick, Fred ^b   D'Cunha, Nicholas ^b   Kast, W Martin ^f   Cobos, Everardo ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

AKAP 4; Cancer; Cancer testis antigens; Immunotherapy; Multiple myeloma

Indexed keywords

CANCER TESTIS ANTIGEN; PROTEIN AKAP 4; UNCLASSIFIED DRUG;

CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MULTIPLE MYELOMA; PRIORITY JOURNAL;

A KINASE ANCHOR PROTEINS; HUMANS; MULTIPLE MYELOMA; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 38349170064     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06940.x     Document Type: Letter

References (10)

1. Atanackovic, D., Arfsten, J., Cao, Y., Gnjatic, S., Schnieders, F., Bartels, K., Schilling, G., Faltz, C., Wolschke, C., Dierlamm, J., Ritter, G., Eiermann, T., Hossfeld, D.K., Zander, A.R., Jungbluth, A.A., Old, L.J., Bokemeyer, C. Kröger, N. (2007) Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation. Blood, 109, 1103 1112.
2. Chiriva-Internati, M., Cobos, E. Kast, W.M. (2007) Advances in immunotherapy of multiple myeloma: from the discovery of tumor associated antigens to clinical trials. International Reviews of Immunology, 2, 1 26.
3. + T cells specific for cancer-germline gene antigens are found in many patients with multiple myeloma and their frequency correlates with disease burden. Blood, 106, 4217 4224.
4. Gouttenfangeas, C. Rammensee, H.G. (2000) Problem solving for tumor immunotherapy. Nature Biotechnology, 18, 491 492.
5. Kyle, R.A. Rajkumar, S.V. (2004) Multiple myeloma. New England Journal of Medicine, 351, 1860 1873.
6. Lim, S.H., Wang, Z., Chiriva-Internati, M. Xue, Y. (2001) Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood, 97, 1508 1510.
7. Pawson, T. Scott, J.D. (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science, 278, 2075 2080.
8. Scanlan, M.J., Gure, A.O., Jungbluth, A.A., Old, L.J. Chen, Y.T. (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunological Reviews, 188, 22 32.
9. Scanlan, M.J., Simpson, A.J. Old, L.J. (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immunity, 4, 1.
10. Turner, R.M., Musse, M.P., Mandal, A., Klotz, K., Jayes, F.C., Herr, J.C., Gerton, G.L., Moss, S.B. Chemes, H.E. (2001) Molecular genetic analysis of two human sperm fibrous sheath proteins, AKAP4 and AKAP3, in men with dysplasia of the fibrous sheath. Journal of Andrology, 22, 302 315.